Coya Therapeutics, Inc. - COYA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 12, 2026 | SCHEDULE 13G | Dr. Reddy's Laboratories, Inc. | 9.7% | 2,272,727 | View |
| Mar 12, 2026 | SCHEDULE 13G | Dr. Reddy's Laboratories SA | 9.7% | 2,272,727 | View |
| Mar 12, 2026 | SCHEDULE 13G | Dr. Reddy's Laboratories Limited | 9.7% | 2,272,727 | View |
| Jan 30, 2026 | SCHEDULE 13G/A | The Vanguard Group | 4.29% | 899,140 | View |
| Jan 28, 2026 | SCHEDULE 13G/A | Orin Hirschman | 5.3% | 1,108,171 | View |
| Jan 28, 2026 | SCHEDULE 13G/A | AIGH Capital Management LLC | 4.7% | 975,404 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.